Urethral cancer
(Redirected from Posterior urethral cancer)
A type of cancer that occurs in the urethra
Urethral cancer is a rare type of cancer that occurs in the urethra, the tube that carries urine from the bladder to the outside of the body. It can affect both men and women, though it is more common in women.
Types[edit | edit source]
Urethral cancer can be classified into several types based on the type of cells involved:
- Squamous cell carcinoma: This is the most common type of urethral cancer, originating in the flat cells lining the urethra.
- Transitional cell carcinoma: This type arises from the cells that are similar to those lining the bladder and is more common in the part of the urethra closest to the bladder.
- Adenocarcinoma: This type develops from glandular cells and is less common.
Symptoms[edit | edit source]
Symptoms of urethral cancer may include:
- Blood in the urine (hematuria)
- Weak or interrupted urine flow
- Frequent urination
- Discharge from the urethra
- A lump or thickness in the perineum or penis
Diagnosis[edit | edit source]
Diagnosis of urethral cancer typically involves a combination of:
- Cystoscopy: A procedure that allows the doctor to view the inside of the bladder and urethra.
- Biopsy: A sample of tissue is taken for examination under a microscope.
- Imaging tests: Such as CT scans, MRIs, or ultrasound to determine the extent of the cancer.
Treatment[edit | edit source]
Treatment options for urethral cancer depend on the stage and location of the cancer and may include:
- Surgery: To remove the cancerous tissue, which may involve partial or total removal of the urethra.
- Radiation therapy: To destroy cancer cells using high-energy rays.
- Chemotherapy: The use of drugs to kill cancer cells, often used in advanced cases.
Prognosis[edit | edit source]
The prognosis for urethral cancer varies depending on the stage at diagnosis and the type of cancer. Early detection and treatment are crucial for improving outcomes.
Epidemiology[edit | edit source]
Urethral cancer is rare, accounting for less than 1% of all cancers. It is more prevalent in women than in men and is more common in individuals over the age of 50.
Related pages[edit | edit source]
References[edit | edit source]
Urethral Cancer[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD